Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China 2023-01-30 23:00
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases 2023-01-30 10:00
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results 2023-01-27 14:52
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane 2023-01-26 14:31
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax 2023-01-26 10:34
Singleron launches single cell eQTL analysis as part of their sequencing service 2023-01-25 19:00
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI 2023-01-20 21:50
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression 2023-01-20 18:00
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases 2023-01-20 09:50
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS 2023-01-20 02:00
Tigermed Completes Acquisition of Marti Farm 2023-01-19 14:59
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List 2023-01-19 11:45
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM 2023-01-18 09:52
IASO Bio Raises Nearly $75 Million in Series C1 Funding 2023-01-18 08:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer 2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs 2023-01-18 00:00
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer 2023-01-17 10:00
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China 2023-01-16 18:00
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
1 59 60 61 62 63 165